登录

Xisoft Raises ¥100 Million in Extended Series A Round

作者: Mailman 2021-06-29 16:39
宁夏熙软科技
企业数据由 动脉橙 提供支持
医疗技术服务商 | 未公开 | 运营中
中国-宁夏
查看

(VCBeat) May. 27, 2021 -- Recently, Shanghai Xisoft Technology Co., Ltd. ("Xisoft"), a digital technology company focusing on hospital economic operation and management, announced that it has received an additional Series A round of 100 million yuan, led by Sequoia Capital China, with participation from the existing investors Gaorong Capital and Sherpa Healthcare Partners.


Xisoft focuses on the digitalization of the economic operation and management in hospitals. The funds raised will continue to accelerate the promotion of a new generation of intelligent operation platforms, promote the R&D of regional health economy operation and regulatory platforms, and build China's leading brand of digital economic management and data services in the field of healthcare.


The new-generation operation management system of Xisoft integrates the technology and business. Xisoft has updated the product and solution capabilities of the intelligent application and mobile online service, combining the application scenarios of hospital management, using modern AI technology and digital twin principle, to establish an integrated digital economy model for real-time online query, real-time business processing. The company is inducing intelligent economic accounting, expense management, distribution platform, and material management to hospitals to enter the stage of intelligent management.


At present, XiSoft's new generation of management system provides 12 application modes for medical institutions, including operations and management integration, business and asset integration, collectivize management, accurate control, cloud platform, supply chain collaboration, human resource management, online apps, internal control system, big data management, decision analysis, collaborative work portal, and smart apps. All levels of medical institutions can, in accordance with the different management requirements, choose the appropriate model.


>>>>

About Sequoia Capital China


Sequoia Capital China, as the "entrepreneur behind entrepreneur", focuses on investment in four directions including technology/media, healthcare, consumer goods/modern services and industrial technology. Over the past 15 years, Sequoia Capital China has invested in nearly 600 enterprises with distinctive technical characteristics, innovative business models, and high growth and development potential.


>>>>

About Gaorong Capital


Gaorong Capital is devoted to creating a better life through innovation. It is dedicated to identifying the leading founders and collaborating with them to achieve long-term value. Gaorong Capital focuses on the investment of innovations in technology and business models along with industrial integration.

相关赛道 药械流通
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

Eno Care Raises ¥10M in Series Pre-A Funding Round

Noah Hospital Logistics Robot Announces ¥120M Series B Financing

RivaMed Receives ¥100M Series B Financing, Providing IoT Solutions of Smart Hospitals

专注智慧医疗领域,联新完成3亿元战略融资

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

【首发】赛业生物董事长、清华珠三角研究院AI中心主任韩蓝青专访:AI+合成生物学助力罕见病基因治疗

2021-06-29
下一篇

Analytical BioSciences Closes Series A4 Financing Led by Sequoia Capital China to Accelerate Single-cell Genomics & AI Based Cancer Therapeutics and Diagnostics

2021-06-29